Archbold Memorial Hospital’s Lewis Hall Singletary Oncology Center was recently granted a three year accreditation by The Commission on Cancer (CoC) of the American College of Surgeons (ACoS). To earn voluntary CoC accreditation, a cancer program must meet 34 CoC quality care standards, be evaluated every three years through a survey process, and maintain levels of excellence in the delivery of comprehensive patient-centered care.
As a CoC-accredited cancer center, clinicians at the Singletary Oncology Center take a multidisciplinary approach to treating cancer as a complex group of diseases that requires consultation among surgeons, medical and radiation oncologists, diagnostic radiologists, pathologists, and other cancer specialists. This multidisciplinary partnership results in improved patient care.
“At Archbold, patients truly have the benefit of comprehensive cancer care,” said Becky Troyer, administrator of the Singletary Oncology Center. “We offer extensive support for our patients and survivors with programs ranging from yoga to art therapy and from exercise programs to support groups. And most notably, our patients have access to world-class physicians, technology and clinical trials, program components that are virtually unheard of for a town the size of Thomasville.”
The CoC Accreditation Program provides the framework for the Singletary Oncology Center to improve its quality of patient care through various cancer-related programs that focus on the full spectrum of cancer care including prevention, early diagnosis, cancer staging, optimal treatment, rehabilitation, life-long follow-up for recurrent disease, and end-of-life care.
The Center also maintains a cancer registry and contributes data to the National Cancer Data Base (NCDB), a joint program of the CoC and American Cancer Society (ACS). This nationwide oncology outcomes database is the largest clinical disease registry in the world. Data on all types of cancer are tracked and analyzed through the NCDB and used to explore trends in cancer care. CoC-accredited cancer centers, like the Singletary Oncology Center, in turn, have access to information derived from this type of data analysis, which is used to create national, regional, and state benchmark reports. These reports help CoC facilities with their quality improvement efforts.
“I’m very proud of our oncology team for receiving their recent voluntary accreditation from the Commission on Cancer,” said Perry Mustian, Archbold president and CEO. “Our oncology team is dedicated to providing the very best care our patients can receive, and this is a testament to their hard work and determination.”